Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (201-210 of 514) with videos related to

Pageof 52
Sort By:
International Wound Journal|September 24, 2025
Use of Artificial Intelligence-Driven Wound Care Management to Enhance Access to Care Rural and Northern CommunitiesShannon Freeman, Matthew J Sargent, Laura Rodriguez Galarza, et al.
Nature Reviews. Cardiology|May 6, 2015
Genotype-based clinical trials in cardiovascular diseaseNaveen L Pereira, Daniel J Sargent, Michael E Farkouh, et al.
Journal of Clinical Epidemiology|February 19, 2005
Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analysesS Michiels, B Baujat, C Mahé, et al.
Contemporary Clinical Trials|May 28, 2013
A phase II flexible screening design allowing for interim analysis and comparison with historical controlWenting Wu, Brian Bot, Yan Hu, et al.
Statistics in Medicine|September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cyclesJun Yin, Rui Qin, Monia Ezzalfani, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
ACS Chemical Neuroscience|January 24, 2013
Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-DNicholas A Moore, Bruce J Sargent, David D Manning, et al.
Biostatistics (Oxford, England)|January 22, 2011
Causal assessment of surrogacy in a meta-analysis of colorectal cancer trialsYun Li, Jeremy M G Taylor, Michael R Elliott, et al.
Chinese Clinical Oncology|December 9, 2014
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Chinese Clinical Oncology|April 6, 2015
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Pageof 52

Showing results (201-210 of 514) with videos related to

Sort By:
Pageof 52
International Wound Journal|September 24, 2025
Use of Artificial Intelligence-Driven Wound Care Management to Enhance Access to Care Rural and Northern CommunitiesShannon Freeman, Matthew J Sargent, Laura Rodriguez Galarza, et al.
Nature Reviews. Cardiology|May 6, 2015
Genotype-based clinical trials in cardiovascular diseaseNaveen L Pereira, Daniel J Sargent, Michael E Farkouh, et al.
Journal of Clinical Epidemiology|February 19, 2005
Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analysesS Michiels, B Baujat, C Mahé, et al.
Contemporary Clinical Trials|May 28, 2013
A phase II flexible screening design allowing for interim analysis and comparison with historical controlWenting Wu, Brian Bot, Yan Hu, et al.
Statistics in Medicine|September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cyclesJun Yin, Rui Qin, Monia Ezzalfani, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
ACS Chemical Neuroscience|January 24, 2013
Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-DNicholas A Moore, Bruce J Sargent, David D Manning, et al.
Biostatistics (Oxford, England)|January 22, 2011
Causal assessment of surrogacy in a meta-analysis of colorectal cancer trialsYun Li, Jeremy M G Taylor, Michael R Elliott, et al.
Chinese Clinical Oncology|December 9, 2014
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Chinese Clinical Oncology|April 6, 2015
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Pageof 52